BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Clinical ink - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Clinical ink
X-ORIGINAL-URL:https://www.clinicalink.com
X-WR-CALDESC:Events for Clinical ink
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221027
DTSTAMP:20250501T125730
CREATED:20221025T080000Z
LAST-MODIFIED:20231013T203610Z
UID:10744-1666656000-1666828799@www.clinicalink.com
SUMMARY:OCT Outsourcing Clinical Trials Nordics
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/oct-nordics-2022/
LOCATION:Scandic\, Copenhagen\, Vester Søgade 6\, Copenhagen\, Denmark
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221012
DTEND;VALUE=DATE:20221014
DTSTAMP:20250501T125730
CREATED:20221012T000000Z
LAST-MODIFIED:20231013T203618Z
UID:10741-1665532800-1665705599@www.clinicalink.com
SUMMARY:OCT Outsourcing Clinical Trials New England
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/oct-new-england-2022/
LOCATION:The Westin\, Copely Place\, Boston\, MA\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221007
DTEND;VALUE=DATE:20221010
DTSTAMP:20250501T125730
CREATED:20221007T080000Z
LAST-MODIFIED:20220930T084935Z
UID:11458-1665100800-1665359999@www.clinicalink.com
SUMMARY:SCRS Global Site Solutions Summit (Hollywood\, Florida)
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/scrs-global-site-solutions-summit/
LOCATION:Diplomat Beach Resort\, 3555 S Ocean Dr.\, Hollywood\, FL\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/SCRS_Logo_1200x600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220928
DTEND;VALUE=DATE:20220930
DTSTAMP:20250501T125730
CREATED:20220928T080000Z
LAST-MODIFIED:20231013T203627Z
UID:10730-1664323200-1664495999@www.clinicalink.com
SUMMARY:OCT Outsourcing Clinical Trials Southern California
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/oct-southern-california-2022/
LOCATION:San Diego Marriott La Jolla\, 4240 La Jolla Village Drive\, La Jolla\, CA\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/OCT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220921
DTEND;VALUE=DATE:20220923
DTSTAMP:20250501T125730
CREATED:20220921T080000Z
LAST-MODIFIED:20220930T084956Z
UID:10734-1663718400-1663891199@www.clinicalink.com
SUMMARY:Global Clinical Trials Connect 2022
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/global-clinical-trials-connect-2022/
LOCATION:Virtual Event
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/SCDM.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220915
DTEND;VALUE=DATE:20220919
DTSTAMP:20250501T125730
CREATED:20220915T080000Z
LAST-MODIFIED:20231013T210910Z
UID:10725-1663200000-1663545599@www.clinicalink.com
SUMMARY:International Congress of Parkinson’s Disease and Movement Disorders
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/parkinsons-disease-movement-disorders-congress-2022/
LOCATION:Marriott Auditorium Hotel and Coference Centre\, Avda de Aragón\, Madrid\, Spain
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/IPMDS.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220913
DTEND;VALUE=DATE:20220915
DTSTAMP:20250501T125730
CREATED:20220913T080000Z
LAST-MODIFIED:20220930T085018Z
UID:10721-1663027200-1663199999@www.clinicalink.com
SUMMARY:DPHARM Disruptive Innovations to Modernize Clinical Research
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/dpharm-disruptive-innovation-conference-2022/
LOCATION:The Westin\, Copely Place\, Boston\, MA\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/DPHARM.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220912
DTEND;VALUE=DATE:20220913
DTSTAMP:20250501T125730
CREATED:20220912T080000Z
LAST-MODIFIED:20231013T205748Z
UID:10716-1662940800-1663027199@www.clinicalink.com
SUMMARY:Mobile Tech in Clinical Trials
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/mobile-tech-clinical-trials-conference-2022/
LOCATION:The Westin\, Copely Place\, Boston\, MA\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/Mobile-Tech.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220911
DTEND;VALUE=DATE:20220915
DTSTAMP:20250501T125730
CREATED:20220911T000000Z
LAST-MODIFIED:20230327T223258Z
UID:10710-1662854400-1663199999@www.clinicalink.com
SUMMARY:SCDM – Society for Clinical Data Management - Annual Conference 2022
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/scdm-annual-conference-2022/
LOCATION:San Antonio\, TX\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/SCDM-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220907
DTEND;VALUE=DATE:20220910
DTSTAMP:20250501T125730
CREATED:20220907T080000Z
LAST-MODIFIED:20230327T223225Z
UID:10705-1662508800-1662767999@www.clinicalink.com
SUMMARY:PCMG “Harnessing Change\, Expanding Expertise\, Growing Sustainability”
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/pcmg-annual-conference-2022/
LOCATION:Doubletree by Hilton\, Krakow\, Poland
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/PCMG.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220731T080000
DTEND;TZID=UTC:20220804T170000
DTSTAMP:20250501T125730
CREATED:20220731T080000Z
LAST-MODIFIED:20221012T091055Z
UID:10701-1659254400-1659632400@www.clinicalink.com
SUMMARY:AAIC 2022 Alzheimer’s Association
DESCRIPTION:Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n									Parkinson’s Disease and Movement Disorder research is accelerating at a faster pace. Subjective assessments and endpoints can now be augmented with richer data sources directly captured via wearables\, sensors\, and mobile technology. Beyond enabling remote data collection\, these new models also drive access to more sensitive\, frequent\, and objective measures of disease progression. Validating digital endpoints across therapeutic areas is complex and requires expertly designed and operated data analysis platforms that can continuously grow and scale to fit-for-purpose digital biomarker development. Real-time\, multi-dimensional data capture—including voice\, gait\, cognition\, movement\, and others\, alongside expanding traditional ePROs—are necessary. New platforms not only capture\, but also generate their own data to further clinical discovery. Discover the complexities of human factors and UX challenges in designing technology for movement disorder studies. Understand the importance of platform-enabled real-time data capture and how to leverage AI and machine learning platforms to drive study insight into disease progression and treatment. Gain the latest insights and ask your questions to experts Joan Severson\, Chief Innovation Officer; David Anderson\, PhD\, Principal Scientist; and moderator Anna Keil\, Senior Software Engineer at Clinical ink. Save your seat today here. https://event.on24.com 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETJoan Severson\, Chief Innovation Officer\, Clinical ink 								\n				\n				\n				\n									The Future of Data Platforms For Digital Biomarkers Accelerating Parkinson’s Disease and Movement Disorders ResearchApril 12\, 2023 | 1:00pm – 2:00pm ETDavid Anderson\, Ph.D.\, Principal Scientist\, Clinical ink
URL:https://www.clinicalink.com/event/alzheimers-association-international-conference-2022/
LOCATION:San Diego Convention Centre\, 111 W Harbor Drive\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2022/08/AA.jpg
END:VEVENT
END:VCALENDAR